Showing results (6041-6050 of 25,889) with videos related to

Sort By:
Pageof 2,589
Anticancer Research|August 28, 2024
First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker DecreaseMotokazu Sato, Qinghong Han, Chihiro Hozumi, et al.
Anticancer Research|August 28, 2024
Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With PembrolizumabKohei Hagiwara, Takashi Matsuki, Takuro Okada, et al.
Anticancer Research|August 28, 2024
Effect of Nivolumab on the Quality of Life in Recurrent/Metastatic Head and Neck CancerShota Fujii, Isaku Okamoto, Takuro Okada, et al.
Anticancer Research|August 28, 2024
Efficacy of Respiration-controlled Radiotherapy Among Patients With Locally Advanced-stage Lung Cancer: A Population-based StudyHung-Jen Chen, Wen-Chien Cheng, Chia-Hung Chen, et al.
Anticancer Research|August 28, 2024
Potential of Nutritional Markers as Predictors After Immunotherapy in Advanced Head and Neck Squamous Cell CarcinomaSatoko Matsumura, Kyoichi Kaira, Kiyomi Kuba, et al.
Anticancer Research|August 28, 2024
Loss of Trefoil Factor 1 Accelerates the Immune Response to Colorectal CancerTakanori Jinno, Junpei Yamaguchi, Atsushi Ogura, et al.
Anticancer Research|August 28, 2024
Stealthy Invader: Clinically Inapparent But Rapidly Progressive Multifocal Metastatic Melanoma Unveiled as Root Cause of Liver FailureAlessia Fraccaroli, Michaela Barnikel, Gabriel Scheubeck, et al.
Anticancer Research|August 28, 2024
Bioinformatics Analysis of the Expression and Prognostic Value of PLAU Gene in Wilms' TumorDing Li, Chen Ding, Fan Huang, et al.
Anticancer Research|June 26, 2024
Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based TherapyNoriyuki Ebi, Hiroyuki Inoue, Fumiyasu Igata, et al.
Anticancer Research|June 26, 2024
Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expressionYusuke Aoki, Yutaro Kubota, Noriyuki Masaki, et al.
Pageof 2,589